The Global Nephrology and Urology Devices Market size is expected to reach $8.5 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,32,278.2 thousand units experiencing a growth of 5.9% (2019-2022).
As it is utilized in a variety of urological issues (e.g., decompression of the perinephric or nephric fluid collection, complications following renal transplants, and urinary fistulas and abnormal connections between the urinary system and other structures (e.g., the skin or intestines), PCN catheters assist in the management of these conditions. Consequently, the PCN Catheters segment would generate approximately 9.68% share of the market by 2030. Therefore, the market is anticipated to be propelled by the rising incidence of urological ailments, including cervical cancer, and the benefits provided by PCN catheters. Some of the factors affecting the market are increasing incidence of kidney and urological disorders, ongoing technological innovations and advancements, and high-cost association and affordability.
According to the National Library of Medicine, chronic kidney disease is a progressive disease affecting>10% of the population globally, amounting to >800 million people. Chronic kidney disease is common in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. The overall burden of kidney and urological disorders, including chronic kidney disease (CKD), kidney stones, urinary tract infections, and urological cancers, is escalating. Thus, the increasing incidence of kidney and urological disorders is a pivotal factor positively influencing the market. Moreover, Technological advancements have led to the development of minimally invasive surgical techniques in urology, including laparoscopy and robotic-assisted surgeries. These approaches reduce patient recovery times, minimize scarring, and improve surgical outcomes. Advanced imaging modalities, such as 3D imaging and virtual reality, enhance visualization capabilities during urological procedures. Due to the continuous evolution of technology, the market is expected to grow.
Additionally, the pandemic prompted a shift In healthcare delivery towards home-based and remote care. For nephrology patients, this meant an increased interest in home dialysis solutions and wearable devices for remote monitoring. Companies offering home-based nephrology solutions saw a surge in demand. Telehealth became a crucial tool for healthcare delivery during the pandemic. Nephrologists and urologists turned to virtual consultations for non-emergency cases and routine follow-ups. As a result, due to these changes, the market is expected to grow significantly in the coming years.
However, High upfront costs for acquiring nephrology and urology devices may limit access to smaller healthcare facilities, clinics, or those in resource-constrained settings. This can lead to disparities in the availability of advanced technologies across different healthcare settings. The substantial investment required to purchase and maintain sophisticated nephrology and urology devices can strain the financial resources of healthcare systems. Hospitals and healthcare providers may face budget constraints that hinder their ability to invest in expensive equipment. Due to the above factors, market growth will be hampered in the coming years.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
As it is utilized in a variety of urological issues (e.g., decompression of the perinephric or nephric fluid collection, complications following renal transplants, and urinary fistulas and abnormal connections between the urinary system and other structures (e.g., the skin or intestines), PCN catheters assist in the management of these conditions. Consequently, the PCN Catheters segment would generate approximately 9.68% share of the market by 2030. Therefore, the market is anticipated to be propelled by the rising incidence of urological ailments, including cervical cancer, and the benefits provided by PCN catheters. Some of the factors affecting the market are increasing incidence of kidney and urological disorders, ongoing technological innovations and advancements, and high-cost association and affordability.
According to the National Library of Medicine, chronic kidney disease is a progressive disease affecting>10% of the population globally, amounting to >800 million people. Chronic kidney disease is common in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. The overall burden of kidney and urological disorders, including chronic kidney disease (CKD), kidney stones, urinary tract infections, and urological cancers, is escalating. Thus, the increasing incidence of kidney and urological disorders is a pivotal factor positively influencing the market. Moreover, Technological advancements have led to the development of minimally invasive surgical techniques in urology, including laparoscopy and robotic-assisted surgeries. These approaches reduce patient recovery times, minimize scarring, and improve surgical outcomes. Advanced imaging modalities, such as 3D imaging and virtual reality, enhance visualization capabilities during urological procedures. Due to the continuous evolution of technology, the market is expected to grow.
Additionally, the pandemic prompted a shift In healthcare delivery towards home-based and remote care. For nephrology patients, this meant an increased interest in home dialysis solutions and wearable devices for remote monitoring. Companies offering home-based nephrology solutions saw a surge in demand. Telehealth became a crucial tool for healthcare delivery during the pandemic. Nephrologists and urologists turned to virtual consultations for non-emergency cases and routine follow-ups. As a result, due to these changes, the market is expected to grow significantly in the coming years.
However, High upfront costs for acquiring nephrology and urology devices may limit access to smaller healthcare facilities, clinics, or those in resource-constrained settings. This can lead to disparities in the availability of advanced technologies across different healthcare settings. The substantial investment required to purchase and maintain sophisticated nephrology and urology devices can strain the financial resources of healthcare systems. Hospitals and healthcare providers may face budget constraints that hinder their ability to invest in expensive equipment. Due to the above factors, market growth will be hampered in the coming years.
End-use Outlook
By end-use, the market is classified into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the highest revenue share in the market in 2022. Owing to their advanced infrastructure and availability of equipment for the diagnosis and treatment of kidney diseases and urological disorders. Teaching hospitals affiliated with medical schools or universities often strongly emphasize providing comprehensive medical services, including specialized care in nephrology and urology. These institutions may invest in cutting-edge devices for education and research purposes. Hospitals offer various services, including dialysis, surgery, and other specialized treatments. In addition, the rising need for minimally invasive procedures further propels segment growth.Application Outlook
Based on application, the market is fragmented into urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others. The urological cancer & BPH segment procured a promising growth rate in the nephrology and urology devices market in 2022. Urological cancers are among the most common cancers worldwide. As per a report by the American Cancer Society in January 2023, bladder cancer ranks fourth in terms of cancer incidence in men. BPH is also a prevalent condition, affecting over half of the male population over the age of 50. Significant technological advancements in urology in recent years have led to the development of more effective and minimally invasive devices for diagnosing and treating urological cancer and BPH.Product Outlook
On the basis of product, the market is segmented into ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, renal dilators, mesh & inserts, and others. In 2022, the urology guidewires segment dominated the market with maximum revenue share. The urology guidewire is advanced through the ureter under fluoroscopic guidance. Once the guidewire reaches the bladder, a stent is threaded over the guidewire and guided into the appropriate position within the ureter. Ureteroscopy involves the insertion of a ureteroscope into the ureter to visualize and treat conditions such as kidney stones or tumors. Guidewires aid in navigating and positioning the ureteroscope during the procedure. The urology guidewire is introduced into the ureter, and the access sheath is advanced over the wire to provide a working channel for other instruments.Regional Outlook
Region-wise, the markets are analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia pacific region acquired a substantial revenue share in the market in 2022. Due to many factors, including heightened awareness regarding renal and urinary disorders, escalating healthcare expenditures, and the enhancement of healthcare infrastructure in the area. The regional market is being propelled by the rising incidence of benign prostatic hyperplasia (BPH), spinal cord injury, and urinary tract infection. In this region, urinary tract infections (UTIs) are exceedingly prevalent. The increasing demand for these devices is also fueled by the critical requirement to develop new systems and supplant and improve current medical infrastructure.The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
Scope of the Study
Market Segments Covered in the Report:
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
- Kidney Diseases
- Bladder Disorders
- Urolithiasis
- Urological Cancer & BPH
- Others
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
- Urology Guidewires
- Stone Basket
- Renal Dilators
- Mesh & Inserts
- Ureteral Catheters
- Urinary Stents
- PCN Catheters
- Others
By Geography (Volume, Thousand Units, USD Billion, 2019-2030)
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Hollister, Inc.
- Medtronic PLC
- Coloplast Group
- Boston Scientific Corporation
- ConvaTec Group PLC
- Baxter International, Inc.
- Asahi Kasei Corporation
- Cook Medical, Inc. (Cook Group)
- Terumo Corporation
- Teleflex Incorporated
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Nephrology And Urology Devices Market by End-use
Chapter 5. Global Nephrology And Urology Devices Market by Application
Chapter 6. Global Nephrology And Urology Devices Market by Product
Chapter 7. Global Nephrology And Urology Devices Market by Region
Chapter 8. Company Profiles
Companies Mentioned
- Hollister, Inc.
- Medtronic PLC
- Coloplast Group
- Boston Scientific Corporation
- ConvaTec Group PLC
- Baxter International, Inc.
- Asahi Kasei Corporation
- Cook Medical, Inc. (Cook Group)
- Terumo Corporation
- Teleflex Incorporated
Methodology
LOADING...
